Lisa V. Sellers, Ph.D., the CEO of Vector Laboratories, highlights the recent surge in mergers and acquisitions (M&A) activity within the life sciences sector.

While M&A is crucial for growth across various industries, many CEOs lack the formal training necessary to develop effective M&A strategies.

Sellers emphasizes the need for a strategic M&A plan that takes into account both short- and long-term market trends, as well as organizational goals.

Thoughtful M&A activities can enhance organizational capabilities, foster a strong company culture, and significantly advance the impact of the industry on biomedical science.

Understanding the culture and leadership of potential M&A targets is essential, as every organization comprises individuals with diverse skills and strengths.

During M&A processes, leaders must uphold their company's core values, balancing growth ambitions with the preservation of organizational identity.

Sellers advises that prioritizing the interests of people, including both the organization's clients and its team members, is critical when evaluating M&A opportunities.